History of BMI — Why It Was Invented and Its Limitations

Adolphe Quetelet and the Average Man (1830s)

Body Mass Index was not invented by a doctor. It was invented by Adolphe Quetelet, a Belgian mathematician, astronomer, and sociologist. In the 1830s, Quetelet was studying what he called l'homme moyen — the average man. He wanted to describe the statistical distribution of physical characteristics across populations, not to assess individual health.

Quetelet observed that in well-nourished adults, weight scaled approximately with the square of height. He published this observation in 1832, creating what he called the Quetelet Index: weight (kg) ÷ height² (m²). He explicitly stated it was a population-level tool and should not be applied to individuals for medical judgement.

Ancel Keys and the Renaming (1972)

Quetelet's index sat largely unused in medicine for over a century. In 1972, American physiologist Ancel Keys published a landmark study testing seven different body weight indices against direct measurements of body density in 7,500 men across five countries.

Keys found that Quetelet's formula correlated best with body fat and was least affected by height variation. He renamed it Body Mass Index and recommended it as the best available proxy for obesity research. Crucially, Keys also noted its limitations — it was better for groups than for individuals, and it could not distinguish fat from muscle.

Clinical Adoption and the 1985 NIH Guidelines

In 1985, the US National Institutes of Health adopted BMI in its first clinical guidelines on obesity. The thresholds used were different from today: overweight was defined as BMI ≥ 27.8 for men and ≥ 27.3 for women.

The Controversial 1998 Threshold Change

In 1998, the NIH revised its guidelines and lowered the overweight threshold to BMI ≥ 25 for all adults — bringing the US in line with WHO standards. This single administrative decision reclassified approximately 29 million Americans as overweight overnight, without any change in their actual body composition.

The change was based on epidemiological evidence linking BMI above 25 to increased disease risk. Critics noted, however, that several of the panellists who set the new thresholds had financial ties to pharmaceutical companies that manufactured weight-loss drugs — a conflict that has never been fully resolved.

The Flegal Controversy (2013)

In 2013, epidemiologist Katherine Flegal published a meta-analysis in JAMA analysing data from nearly three million people. The finding was counterintuitive: people in the "overweight" BMI category (25–29.9) had lower all-cause mortality than those in the "normal" category. Mildly obese individuals (BMI 30–34.9) showed no increased mortality compared to normal weight.

The paper sparked significant controversy in the medical community. Some researchers argued it reflected the "obesity paradox" — that excess weight may provide protective reserves during illness. Others pointed to methodological issues including reverse causation (sick people lose weight before death, lowering their BMI). The debate continues.

The Asian Expansion (2004)

In 2004, a WHO Expert Consultation published in The Lancet proposed lower BMI thresholds for Asian populations. This was a significant evolution — acknowledging that the original thresholds were derived from a narrow population base and did not apply universally. Our calculator reflects this by offering three separate standards.

What This History Tells Us

BMI was a convenience tool that worked well enough, at a population level, to get adopted globally. It was never validated for individual clinical diagnosis. The thresholds have been revised by committee decisions that mixed epidemiological evidence with policy and commercial interests. And the tool was designed for one ethnic population and then applied globally without adjustment for nearly five decades.

None of this means BMI is useless. It means it should be used as it was designed: as a first screening step, not a final verdict.

Calculate your BMI →